Literature DB >> 24439219

Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma.

Andre L Moreira1, Philippe Joubert2, Robert J Downey3, Natasha Rekhtman2.   

Abstract

The 2011 International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society classification of pulmonary adenocarcinoma recognizes the prognostic significance of different histologic patterns but does not address the issue of tumor grade. We previously developed an objective and prognostic grading system for pulmonary adenocarcinomas that is based on associating patterns with their metastatic potential. The best prognostic stratification was achieved by summing the grades of the 2 most predominant patterns (histologic score). Here, we extend this work by evaluating the prognostic importance of variant patterns of adenocarcinoma, which are not recognized by the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Pathologic specimens from 249 resected stage I adenocarcinomas were reviewed. The proportions of standard and nonstandard patterns (cribriform and fused glands) were recorded for each case. The associations between the presence of standard and nonstandard patterns, tumor histologic score, and disease-free survival were evaluated. Cribriform and fused gland patterns were observed in 15% and 29% of tumors, respectively. These nonstandard patterns each composed 10% to 100% of the entire tumors but were the predominant pattern in only 5% and 7% of tumors, respectively. The presence of complex glandular patterns was associated with solid pattern (P < .001) and high histologic score (P < .0001). Disease-free survival for tumors with predominant complex glandular patterns was similar to that for high-grade tumors (P = .932) and was significantly worse than that for low- and intermediate-grade tumors (P = .0025). Complex glandular patterns have a significant prognostic value and should be considered patterns of high-grade adenocarcinoma.
© 2014.

Entities:  

Keywords:  Adenocarcinoma; Complex gland; Cribriform; Grade

Mesh:

Substances:

Year:  2013        PMID: 24439219     DOI: 10.1016/j.humpath.2013.10.011

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  20 in total

Review 1.  [Grading of lung cancer].

Authors:  R M Bohle; P A Schnabel
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

Review 2.  [The new TNM classification for lung tumors : Changes and the assessment of multiple tumor foci].

Authors:  A Harms; M Kriegsmann; L Fink; F Länger; A Warth
Journal:  Pathologe       Date:  2017-02       Impact factor: 1.011

Review 3.  Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).

Authors:  Elizabeth R Tang; Andrew M Schreiner; Bradley B Pua
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 4.  [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].

Authors:  A Warth
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

Review 5.  Lung cancer: developments, concepts, and specific aspects of the new WHO classification.

Authors:  Iver Petersen; Arne Warth
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-22       Impact factor: 4.553

6.  Low-depth whole genome sequencing reveals copy number variations associated with higher pathologic grading and more aggressive subtypes of lung non-mucinous adenocarcinoma.

Authors:  Zheng Wang; Lin Zhang; Lei He; Di Cui; Chenglong Liu; Liangyu Yin; Min Zhang; Lei Jiang; Yuyan Gong; Wang Wu; Bi Liu; Xiaoyu Li; David S Cram; Dongge Liu
Journal:  Chin J Cancer Res       Date:  2020-06       Impact factor: 5.087

7.  Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study.

Authors:  Likun Hou; Tingting Wang; Donglai Chen; Chunyan Wu; Chang Chen; Yunlang She; Jiajun Deng; Minglei Yang; Yu Zhang; Mengmeng Zhao; Yifan Zhong; Minjie Ma; Guofang Zhao; Yongbing Chen; Dong Xie; Yuming Zhu; Qiankun Chen
Journal:  Mod Pathol       Date:  2022-01-10       Impact factor: 7.842

8.  A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.

Authors:  Andre L Moreira; Paolo S S Ocampo; Yuhe Xia; Hua Zhong; Prudence A Russell; Yuko Minami; Wendy A Cooper; Akihiko Yoshida; Lukas Bubendorf; Mauro Papotti; Giuseppe Pelosi; Fernando Lopez-Rios; Keiko Kunitoki; Dana Ferrari-Light; Lynette M Sholl; Mary Beth Beasley; Alain Borczuk; Johan Botling; Elisabeth Brambilla; Gang Chen; Teh-Ying Chou; Jin-Haeng Chung; Sanja Dacic; Deepali Jain; Fred R Hirsch; David Hwang; Sylvie Lantuejoul; Dongmei Lin; John W Longshore; Noriko Motoi; Masayuki Noguchi; Claudia Poleri; Natasha Rekhtman; Ming-Sound Tsao; Erik Thunnissen; William D Travis; Yasushi Yatabe; Anja C Roden; Jillian B Daigneault; Ignacio I Wistuba; Keith M Kerr; Harvey Pass; Andrew G Nicholson; Mari Mino-Kenudson
Journal:  J Thorac Oncol       Date:  2020-06-17       Impact factor: 15.609

9.  Expression profiles and initial confirmation of long noncoding RNAs in Chinese patients with pulmonary adenocarcinoma.

Authors:  Xin Zhao; Wen Zhu; Wangjian Zha; Feifei Chen; Zhenzhen Wu; Yanan Liu; Mao Huang
Journal:  Onco Targets Ther       Date:  2014-07-01       Impact factor: 4.147

10.  Expression of EGFR and molecules downstream to PI3K/Akt, Raf-1-MEK-1-MAP (Erk1/2), and JAK (STAT3) pathways in invasive lung adenocarcinomas resected at a single institution.

Authors:  Alba Fabiola Torres; Cleto Nogueira; Juliana Magalhaes; Igor Santos Costa; Alessa Aragao; Antero Gomes Neto; Filadelfia Martins; Fabio Tavora
Journal:  Anal Cell Pathol (Amst)       Date:  2014-12-18       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.